EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Splenic T2 signal intensity loss on MRI is associated with disease burden in multiple myeloma

Christian Neelsen, Christos Sachpekidis, Lukas John, Peter Neher, Elias Mai, Martin Grözinger, Daniel Paech, Antonia Dimitrakopoulou-Strauss, Felix T Kurz, Sandra Sauer, Marc S Raab, Heinz-Peter Schlemmer und 2 weitere

European Radiology · 2024

DOI: 10.1007/s00330-024-11191-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Radiology, 2024. Verfasst von Christian Neelsen und 13 weiteren Autor:innen. Beteiligte Einrichtung: German Cancer Research Center, Division of Radiology, Heidelberg, Germany. c.neelsen@dkfz.de. Hauptthemen laut MEDLINE: Multiple Myeloma, Spleen, Magnetic Resonance Imaging. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study aims to evaluate correlations between spleen signal changes in different MRI sequences and bone marrow plasma cell infiltration as potential indicator of disease burden in multiple myeloma (MM) patients. Materials and methods We retrospectively analyzed 45 patients with newly diagnosed MM that underwent whole-body MRI with axial DWI at b-values 50 (b50) and 800 (b800), and coronal T1 and T2 fast spin-echo (T2-TSE) imaging. A subcohort of 39 patients had concomitant [ 18 F]FDG PET/CT. The spleen was segmented in all MRI sequences and signal intensities were normalized. MR signal intensities and ADC values were correlated with bone marrow plasma cell infiltration from biopsy, laboratory markers (Beta 2-microglobulin, M-Protein, Red blood count (RBC), Hemoglobin, Hematocrit, Total protein, Creatinine), clinical data (ISS stages, high-risk chromosomal aberrations), and standardized uptake value (SUV) in the spleen as well as spleen-to-liver and spleen-to-blood pool SUV ratios on [ 18 F]FDG PET-CT.

Results

Bone marrow plasma cell infiltration was negatively correlated with (normalized) mean splenic signal intensity on DWI-b50, DWI-b800, and T2-TSE images ( r = −0.64, p < 0.001, r = −0.58, p < 0.001, and r = −0.66, p < 0.001, respectively) while there was no correlation with the apparent diffusion coefficient or spleen size ( p = 0.52). In the subgroup analysis of 39 patients with concomitant [ 18 F]FDG PET-CT, there was no correlation of normalized splenic [ 18 F]FDG uptake either with MR spleen signal (for T2 p = 0.64) or with bone marrow plasma cell infiltration ( p = 0.37).

Conclusions

Our findings reveal a significant association between spleen signal intensity especially on normalized T2-weighted images and tumor burden. Key Points Question What changes occur in spleen signal on MRI as tumor load marker changes in multiple myeloma (MM)?

Findings

Spleen signal intensity, particularly on T2-weighted MRI, negatively correlates with bone marrow plasma cell infiltration and laboratory markers of tumor burden. Clinical relevance Standardized quantification of splenic T2 signal is proposed as a new marker for MM disease burden. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaSpleenMagnetic Resonance ImagingHumansMaleFemaleMiddle AgedAgedRetrospective StudiesPositron Emission Tomography Computed TomographyFluorodeoxyglucose F18AdultAged, 80 and overTumor BurdenWhole Body ImagingRadiopharmaceuticalsBone Marrow

Stichwörter der Autor:innen

Multiparametric magnetic resonance imagingMultiple myelomaNeoplasm stagingPositron emission tomography computed tomographySpleen

Substanzen

Fluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • German Cancer Research Center, Division of Radiology, Heidelberg, Germany. c.neelsen@dkfz.de.
  • German Cancer Research Center, Clinical Cooperation Unit Nuclear Medicine, Heidelberg, Germany.
  • Department of Medicine V, Multiple Myeloma Section, University Hospital Heidelberg, Heidelberg, Germany.
  • Medical Image Computing, German Cancer Research Center, Heidelberg, Germany.
  • German Cancer Research Center, Division of Radiology, Heidelberg, Germany.
  • Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, US.

Zitieren

APA

Neelsen, C., Sachpekidis, C., John, L., Neher, P., Mai, E., Grözinger, M., Paech, D., Dimitrakopoulou-Strauss, A., Kurz, F. T., Sauer, S., Raab, M. S., Schlemmer, H. P., Wennmann, M., & Weinhold, N. (2024). Splenic T2 signal intensity loss on MRI is associated with disease burden in multiple myeloma. European Radiology. https://doi.org/10.1007/s00330-024-11191-8

Vancouver

Neelsen C, Sachpekidis C, John L, Neher P, Mai E, Grözinger M, et al. Splenic T2 signal intensity loss on MRI is associated with disease burden in multiple myeloma. European Radiology. 2024. doi:10.1007/s00330-024-11191-8

BibTeX
@article{Neelsen2024,
  author = {Neelsen, Christian and Sachpekidis, Christos and John, Lukas and Neher, Peter and Mai, Elias and Grözinger, Martin and Paech, Daniel and Dimitrakopoulou-Strauss, Antonia and Kurz, Felix T and Sauer, Sandra and Raab, Marc S and Schlemmer, Heinz-Peter and Wennmann, Markus and Weinhold, Niels},
  title = {Splenic T2 signal intensity loss on MRI is associated with disease burden in multiple myeloma},
  journal = {European Radiology},
  year = {2024},
  doi = {10.1007/s00330-024-11191-8}
}
Kostenlos starten →